Literature DB >> 6976935

Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a). Investigations on their ability to induce platelet secretion.

S Meuer, T E Hugli, R H Andreatta, U Hadding, D Bitter-Suermann.   

Abstract

Several anaphylatoxic substances (human C3a, guinea pig C3a, human C4a, guinea pig C5a, and a synthetic C3a-related hexapeptide) were compared with regard to their ability to induce secretion of [3H] serotonin from guinea pig platelets. Functional identity of the C3a preparations, C4a, and the hexapeptide was demonstrated by the phenomenon of crossed desensitization. Whereas C3a of human and guinea pig origin proved to be qualitatively and quantitatively identical, C4a expressed only 3% of the activity of the C3 fragments on a molar basis. Investigations with goat anti-guinea pig C3a demonstrate that human and guinea pig C3a possess one antigenic determinant in common; however, this determinant is not the C-terminal amino acid sequence. Addition of the anaphylatoxins with low doses of thrombin led to a potentiation of [3H] serotonin release from the platelets. Under these conditions C3a concentrations of 1.5 X 10(-10) mumol/liter (65 pg of C3a) could be detected. Thus the platelet system represents the most sensitive in vitro assay known for evaluation of biological activity of the C3a anaphylatoxins.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6976935     DOI: 10.1007/BF00911092

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  22 in total

1.  The primary structure of porcine C3a anaphylatoxin.

Authors:  N C Corbin; T E Hugli
Journal:  J Immunol       Date:  1976-09       Impact factor: 5.422

2.  Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

Authors:  H N Fernandez; P M Henson; A Otani; T E Hugli
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

3.  The reaction of zymosan with the properdin system: isolation of purified factor D from guinea pig serum and study of its reaction characteristics.

Authors:  V Brade; A Nicholson; G D Lee; M M Mayer
Journal:  J Immunol       Date:  1974-05       Impact factor: 5.422

4.  Comparative study on biological effects of the guinea pig complement-peptide C3a and C3a-related synthetic oligopeptides.

Authors:  D Bitter-Suermann; S Becker; S Meuer; H U Schorlemmer; U Hadding; R Andreatta
Journal:  Mol Immunol       Date:  1980-10       Impact factor: 4.407

5.  Bypass-activation of the complement system starting with C3. I. Generation and function of an enzyme from a factor of guinea-pig serum and cobra venom.

Authors:  D Bitter-Suermann; M Dierich; W König; U Hadding
Journal:  Immunology       Date:  1972-09       Impact factor: 7.397

6.  Platelet activation: a new biological activity of guinea-pig C3a anaphylatoxin.

Authors:  S Becker; S Meuer; U Hadding; D Bitter-Suermann
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

7.  C4a: the third anaphylatoxin of the human complement system.

Authors:  J P Gorski; T E Hugli; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

8.  The anaphylatoxic peptide C3a of guinea pig complement. I. Purification, physicochemical and antigenetic properties.

Authors:  S Meuer; S Becker; U Hadding; D Bitter-Suermann
Journal:  Z Immunitatsforsch Immunobiol       Date:  1978-03

9.  Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator.

Authors:  E H Vallota; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1973-05-01       Impact factor: 14.307

10.  The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.

Authors:  C G Cochrane; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1968-02-01       Impact factor: 14.307

View more
  8 in total

Review 1.  C4a: An Anaphylatoxin in Name Only.

Authors:  Scott R Barnum
Journal:  J Innate Immun       Date:  2015-02-06       Impact factor: 7.349

Review 2.  Relationships among the complement, kinin, coagulation, and fibrinolytic systems.

Authors:  J S Sundsmo; D S Fair
Journal:  Springer Semin Immunopathol       Date:  1983

3.  In vivo effects of C3a on neutrophils and its contribution to inflammatory lung processes in a guinea-pig model.

Authors:  T Hoffmann; E C Böttger; H P Baum; M Messner; U Hadding; D Bitter-Suermann
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

Review 4.  Anaphylatoxins: their role in bacterial infection and inflammation.

Authors:  Pieter-Jan Haas; Jos van Strijp
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

5.  A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.

Authors:  W Bautsch; T Kretzschmar; T Stühmer; A Kola; M Emde; J Köhl; A Klos; D Bitter-Suermann
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

Review 6.  Of mice and men: the relevance of the mouse to the study of human SLE.

Authors:  D J Birmingham; B H Rovin; C Y Yu; L A Hebert
Journal:  Immunol Res       Date:  2001       Impact factor: 4.505

7.  Complement factor C4a does not activate protease-activated receptor 1 (PAR1) or PAR4 on human platelets.

Authors:  Xu Han; Maria de la Fuente; Marvin T Nieman
Journal:  Res Pract Thromb Haemost       Date:  2020-12-04

8.  Human platelet activation by C3a and C3a des-arg.

Authors:  M J Polley; R L Nachman
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.